Skip to main content
logo
PolyPeptide Group AG (SWX:PPGN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
24.45
-2.20 (-8.26%)
Mar 13, 2026, 4:14 PM CET

PolyPeptide Group AG Revenue

In the year 2025, PolyPeptide Group AG had annual revenue of 391.95M EUR with 16.38% growth. PolyPeptide Group AG had revenue of 167.10M in the half year ending June 30, 2025, with 26.75% growth.

Revenue
391.95M EUR
Revenue Growth
+15.70%
P/S Ratio
2.41
Revenue / Employee
279.96K EUR
Employees
1,400
Market Cap
879.22M CHF

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025391.95M55.16M16.38%
Dec 31, 2024336.79M16.42M5.13%
Dec 31, 2023320.37M39.39M14.02%
Dec 31, 2022280.98M-1.15M-0.41%
Dec 31, 2021282.13M57.83M25.78%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Roche Holding AG63.36B
Novartis AG44.94B
Lonza Group AG6.53B
Galderma Group AG4.16B
Aevis Victoria955.96M
SKAN Group AG332.13M
Medartis Holding AG236.34M
Basilea Pharmaceutica AG232.38M
Revenue Rankings

PolyPeptide Group AG News

More News